Stati Uniti - inglese - NLM (National Library of Medicine)

preferred pharmaceuticals, inc. - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - hydroquinone 40 mg in 1 g - hydroquinone usp, 4% skin bleaching cream is indicated for the gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. prior history of sensitivity or allergic reaction to hydroquinone or to any of the ingredients of the product. the safety of topical hydroquinone use during pregnancy or for children (12 years and under) has not been established.

Stati Uniti - inglese - NLM (National Library of Medicine)

bi-coastal pharma international llc - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - hydroquinone 40 mg in 1 g - hydroquinone usp, 4% skin bleaching cream is indicated for the gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. prior history of sensitivity or allergic reaction to hydroquinone or to any of the ingredients of the product. the safety of topical hydroquinone use during pregnancy or for children (12 years and under) has not been established.

Stati Uniti - inglese - NLM (National Library of Medicine)

twi pharmaceuticals, inc. - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - hydroquinone 40 mg in 1 g - hydroquinone usp, 4% skin bleaching cream is indicated for the gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. prior history of sensitivity or allergic reaction to hydroquinone or to any of the ingredients of the product. the safety of topical hydroquinone use during pregnancy or for children (12 years and under) has not been established.

Stati Uniti - inglese - NLM (National Library of Medicine)

taro pharmaceuticals u.s.a., inc. - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - hydroquinone 40 mg in 1 g - lustra® and lustra-af® are indicated for the gradual treatment of ultraviolet induced dyschromia and discoloration resulting from the use of oral contraceptives, pregnancy, hormone replacement therapy, or skin trauma. lustra® and lustra-af® are contraindicated in any patient that has a prior history of hypersensitivity or allergic reaction to hydroquinone or any of the other ingredients. the safety of topical hydroquinone use during pregnancy or on children (12 years and under) has not been established.

Stati Uniti - inglese - NLM (National Library of Medicine)

twi pharmaceuticals, inc. - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - hydroquinone usp, 4% time release cream is indicated for the gradual treatment of ultraviolet induced dyschromia and discoloration (such as chloasma, melasma, freckles, and senile lentigines) resulting from the use of oral contraceptives, pregnancy, hormone replacement therapy, or skin trauma. prior history of sensitivity or allergic reaction to hydroquinone or to any of the ingredients of the product. the safety of topical hydroquinone use during pregnancy or on children (12 years and under) has not been established.

Stati Uniti - inglese - NLM (National Library of Medicine)

zo skin health, inc. - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - hydroquinone 0.04 g in 1 g - for the gradual bleaching of hyperpigmented skin conditions such as cholasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. prior history of sensitivity or allergic reaction to hydroquinone or to any other ingredient in this product. the safety of topical hydroquinone use during pregnancy or in children (21 years and under) has not been established.

Stati Uniti - inglese - NLM (National Library of Medicine)

marlex pharmaceuticals, inc. - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - hydroquinone usp, 4% skin bleaching cream is indicated for the gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. prior history of sensitivity or allergic reaction to hydroquinone or to any of the ingredients of the product. the safety of topical hydroquinone use during pregnancy or for children (12 years and under) has not been established.

Stati Uniti - inglese - NLM (National Library of Medicine)

the skin atelier, inc. - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - hydroquinone 0.04 g in 1 g - gently smooth over entire face. let product absorb at least 2 minutes before applying lotion. this lightening treatment lightens the skin with minimal irritation. brightens sun damage, melasma and dark spots on skin. this lightening treatment lightens skin with minimal irritation. brightens sun damage, melasma and dark spots on skin.

Stati Uniti - inglese - NLM (National Library of Medicine)

westminster pharmaceuticals, llc - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - hydroquinone usp, 4% skin bleaching cream is indicated for the gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. prior history of sensitivity or allergic reaction to hydroquinone or to any of the ingredients of the product. the safety of topical hydroquinone use during pregnancy or for children (12 years and under) has not been established.

Stati Uniti - inglese - NLM (National Library of Medicine)

syntenza pharmaceuticals llc - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - hydroquinone usp, 4% skin bleaching cream is indicated for the gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. prior history of sensitivity or allergic reaction to hydroquinone or to any of the ingredients of the product. the safety of topical hydroquinone use during pregnancy or for children (12 years and under) has not been established.